Phase II Study of Doxorubicin and Avastin® in Sarcoma.

This study has been terminated.

( The study has been terminated due to low accrual. )

Study NCT00755261 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: September 17, 2008 Last Updated: January 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)